Christian Patricio Camacho Limas , Raquel Gerson Cwilich , María del Ángel Góngora Jurado , Marcos López Naveda
{"title":"中性粒细胞-淋巴细胞指数与黑色素瘤初始诊断临床分期的关系","authors":"Christian Patricio Camacho Limas , Raquel Gerson Cwilich , María del Ángel Góngora Jurado , Marcos López Naveda","doi":"10.1016/j.gamo.2016.08.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Measure and compare the neutrophil-lymphocyte ratio (NLR) with clinical stage of melanoma at diagnosis. To assess the association between NLR at initial diagnosis of melanoma and clinical stage at different stages of patients from a private cancer centre of Mexico City.</p></div><div><h3>Methods</h3><p>An observational, analytical, retrospective study was conducted on 63 patients with a melanoma diagnosis by reviewing medical records. The study included all patients diagnosed with melanoma biopsy reported in the period from 2002 to 2015.</p></div><div><h3>Results</h3><p>Of the 63 patients studied, a mean LNR of 4.1 (SD 6.44) was obtained. The median was 2.7, and a correlation of 58% was found between LNR (><!--> <!-->2.7) and the outcome of death in the subgroup of patients in clinical stage<!--> <!-->><!--> <!-->IIA.</p></div><div><h3>Conclusions</h3><p>This study shows a trend association between LNR (><!--> <!-->2.7) and clinical stage, which was not statistically significant due to the limited sample size. A single correlation was found with the subgroup of patients with advanced disease and an LNR<!--> <!-->><!--> <!-->2.7 and outcome of death, but not in the other variables (progression and recurrence). This work is objective biochemical proof that this accessible and inexpensive tool could provide prognostic information for advanced-stage melanoma.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"15 5","pages":"Pages 268-277"},"PeriodicalIF":0.1000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2016.08.002","citationCount":"2","resultStr":"{\"title\":\"Asociación del índice neutrófilo-linfocito y el estadio clínico en el diagnóstico inicial de melanoma\",\"authors\":\"Christian Patricio Camacho Limas , Raquel Gerson Cwilich , María del Ángel Góngora Jurado , Marcos López Naveda\",\"doi\":\"10.1016/j.gamo.2016.08.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Measure and compare the neutrophil-lymphocyte ratio (NLR) with clinical stage of melanoma at diagnosis. To assess the association between NLR at initial diagnosis of melanoma and clinical stage at different stages of patients from a private cancer centre of Mexico City.</p></div><div><h3>Methods</h3><p>An observational, analytical, retrospective study was conducted on 63 patients with a melanoma diagnosis by reviewing medical records. The study included all patients diagnosed with melanoma biopsy reported in the period from 2002 to 2015.</p></div><div><h3>Results</h3><p>Of the 63 patients studied, a mean LNR of 4.1 (SD 6.44) was obtained. The median was 2.7, and a correlation of 58% was found between LNR (><!--> <!-->2.7) and the outcome of death in the subgroup of patients in clinical stage<!--> <!-->><!--> <!-->IIA.</p></div><div><h3>Conclusions</h3><p>This study shows a trend association between LNR (><!--> <!-->2.7) and clinical stage, which was not statistically significant due to the limited sample size. A single correlation was found with the subgroup of patients with advanced disease and an LNR<!--> <!-->><!--> <!-->2.7 and outcome of death, but not in the other variables (progression and recurrence). This work is objective biochemical proof that this accessible and inexpensive tool could provide prognostic information for advanced-stage melanoma.</p></div>\",\"PeriodicalId\":41581,\"journal\":{\"name\":\"Gaceta Mexicana de Oncologia\",\"volume\":\"15 5\",\"pages\":\"Pages 268-277\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2016-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.gamo.2016.08.002\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gaceta Mexicana de Oncologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665920116300761\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta Mexicana de Oncologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665920116300761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Asociación del índice neutrófilo-linfocito y el estadio clínico en el diagnóstico inicial de melanoma
Objectives
Measure and compare the neutrophil-lymphocyte ratio (NLR) with clinical stage of melanoma at diagnosis. To assess the association between NLR at initial diagnosis of melanoma and clinical stage at different stages of patients from a private cancer centre of Mexico City.
Methods
An observational, analytical, retrospective study was conducted on 63 patients with a melanoma diagnosis by reviewing medical records. The study included all patients diagnosed with melanoma biopsy reported in the period from 2002 to 2015.
Results
Of the 63 patients studied, a mean LNR of 4.1 (SD 6.44) was obtained. The median was 2.7, and a correlation of 58% was found between LNR (> 2.7) and the outcome of death in the subgroup of patients in clinical stage > IIA.
Conclusions
This study shows a trend association between LNR (> 2.7) and clinical stage, which was not statistically significant due to the limited sample size. A single correlation was found with the subgroup of patients with advanced disease and an LNR > 2.7 and outcome of death, but not in the other variables (progression and recurrence). This work is objective biochemical proof that this accessible and inexpensive tool could provide prognostic information for advanced-stage melanoma.